Home Halogens (+/-)-chloro-APB

(+/-)-chloro-APB

CAS No.:
74115-01-8
Catalog Number:
AG00FC1U
Molecular Formula:
C19H21BrClNO2
Molecular Weight:
410.7325
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
99%
1 week
United States
$222
- +
10mg
99%
1 week
United States
$323
- +
25mg
99%
1 week
United States
$590
- +
50mg
99%
1 week
United States
$1023
- +
100mg
99%
1 week
United States
$1807
- +
Product Description
Catalog Number:
AG00FC1U
Chemical Name:
(+/-)-chloro-APB
CAS Number:
74115-01-8
Molecular Formula:
C19H21BrClNO2
Molecular Weight:
410.7325
MDL Number:
MFCD00069235
IUPAC Name:
9-chloro-5-phenyl-3-prop-2-enyl-1,2,4,5-tetrahydro-3-benzazepine-7,8-diol;hydrobromide
InChI:
InChI=1S/C19H20ClNO2.BrH/c1-2-9-21-10-8-14-15(11-17(22)19(23)18(14)20)16(12-21)13-6-4-3-5-7-13;/h2-7,11,16,22-23H,1,8-10,12H2;1H
InChI Key:
WLXGFAVTAAQOFH-UHFFFAOYSA-N
SMILES:
C=CCN1CCc2c(C(C1)c1ccccc1)cc(c(c2Cl)O)O.Br
Properties
Complexity:
399  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
409.044g/mol
Formal Charge:
0
Heavy Atom Count:
24  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
3  
Isotope Atom Count:
0
Molecular Weight:
410.736g/mol
Monoisotopic Mass:
409.044g/mol
Rotatable Bond Count:
3  
Topological Polar Surface Area:
43.7A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20121001
Patterns of brain glucose metabolism induced by phosphodiesterase 10A inhibitors in the mouse: a potential translational biomarker. The Journal of pharmacology and experimental therapeutics 20111001
Dopamine D1 receptor signaling system regulates ryanodine receptor expression after intermittent exposure to methamphetamine in primary cultures of midbrain and cerebral cortical neurons. Journal of neurochemistry 20110901
Molecular switch from L-type Ca v 1.3 to Ca v 1.2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity. The Journal of neuroscience : the official journal of the Society for Neuroscience 20101215
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice. Brain research bulletin 20100531
Selective D1 agonism but not D2 antagonism is reflected in cAMP and cGMP levels in rat CSF. Brain research bulletin 20100405
AMPA receptor subunit GluR1 downstream of D-1 dopamine receptor stimulation in nucleus accumbens shell mediates increased drug reward magnitude in food-restricted rats. Neuroscience 20100217
Inhibition of specific adenylyl cyclase isoforms by lithium and carbamazepine, but not valproate, may be related to their antidepressant effect. Bipolar disorders 20091201
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
Blockade of neurokinin-3 receptors modulates dopamine-mediated behavioral hyperactivity. Neuropharmacology 20090901
Pharmacological characterization of harmaline-induced tremor activity in mice. European journal of pharmacology 20090815
Dopaminergic modulation of olfactory bulb processing affects odor discrimination learning in rats. Behavioral neuroscience 20090801
Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats. Psychopharmacology 20090601
D1/D2-dopamine receptor agonist dihydrexidine stimulates inspiratory motor output and depresses medullary expiratory neurons. American journal of physiology. Regulatory, integrative and comparative physiology 20090601
Reward-potentiating effects of D-1 dopamine receptor agonist and AMPAR GluR1 antagonist in nucleus accumbens shell and their modulation by food restriction. Psychopharmacology 20090301
Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 20090128
Age dependence of motor activity and sensitivity to dopamine receptor 1 agonist, SKF82958, of inbred AKR/J, BALB/c, C57BL/6J, SAMR1, and SAMP6 strains. Brain research 20090123
Effects of the MEK inhibitor, SL-327, on rewarding, motor- and cellular-activating effects of D-amphetamine and SKF-82958, and their augmentation by food restriction in rat. Psychopharmacology 20090101
Biperiden enhances L-DOPA methyl ester and dopamine D(l) receptor agonist SKF-82958 but antagonizes D(2)/D(3) receptor agonist rotigotine antihemiparkinsonian actions. European journal of pharmacology 20081203
Lithium preferentially inhibits adenylyl cyclase V and VII isoforms. The international journal of neuropsychopharmacology 20080601
Augmented D1 dopamine receptor signaling and immediate-early gene induction in adult striatum after prenatal cocaine. Biological psychiatry 20080601
High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats. Journal of psychopharmacology (Oxford, England) 20080101
Pharmacological characterization of the effects of dopamine D(1) agonists on eye blinking in rats. Behavioural pharmacology 20071201
Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 20071128
Activation of nigral and pallidal dopamine D1-like receptors modulates basal ganglia outflow in monkeys. Journal of neurophysiology 20070901
Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: a parallel dialysis and behavioural study in rats. The international journal of neuropsychopharmacology 20070601
Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys. The Journal of pharmacology and experimental therapeutics 20070601
Delayed L-DOPA-induced hyperalgesia. Pharmacology, biochemistry, and behavior 20061101
Receptor recycling mediates plasma membrane recovery of dopamine D1 receptors in dendrites and axons after agonist-induced endocytosis in primary cultures of striatal neurons. Synapse (New York, N.Y.) 20060901
Behavioral and molecular effects of dopamine D1 receptor stimulation during naloxone-precipitated morphine withdrawal. The Journal of neuroscience : the official journal of the Society for Neuroscience 20060614
Changes in accumbal and pallidal pCREB and deltaFosB in morphine-sensitized rats: correlations with receptor-evoked electrophysiological measures in the ventral pallidum. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060601
Effects of dopamine D1-like receptor agonists on food-maintained operant behavior in rats. Behavioural pharmacology 20060601
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats. European journal of pharmacology 20051228
Combined blockade of AMPA and NMDA glutamate receptors reduces levodopa-induced motor complications in animal models of PD. Experimental neurology 20051201
Comparison of basal and D-1 dopamine receptor agonist-stimulated neuropeptide gene expression in caudate-putamen and nucleus accumbens of ad libitum fed and food-restricted rats. Brain research. Molecular brain research 20051130
Differences between A 68930 and SKF 82958 could suggest synergistic roles of D1 and D5 receptors. Pharmacology, biochemistry, and behavior 20051101
The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats. Journal of neurochemistry 20051001
Serotonin 5-HT2A but not 5-HT2C receptor antagonism reduces hyperlocomotor activity induced in dopamine-depleted rats by striatal administration of the D1 agonist SKF 82958. Neuropharmacology 20050901
A comparison of the locomotor stimulant effects of D1-like receptor agonists in mice. Pharmacology, biochemistry, and behavior 20050801
D1-dopamine receptor agonists prevent and reverse opiate depression of breathing but not antinociception in the cat. American journal of physiology. Regulatory, integrative and comparative physiology 20050701
Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism. Synapse (New York, N.Y.) 20050701
Dopamine D1 receptor interaction with arrestin3 in neostriatal neurons. Journal of neurochemistry 20050401
Role of GABA(A) receptors in the retrorubral field and ventral pallidum in rat jaw movements elicited by dopaminergic stimulation of the nucleus accumbens shell. European journal of pharmacology 20050307
Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice. Alcohol (Fayetteville, N.Y.) 20050201
Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats. Methods and findings in experimental and clinical pharmacology 20050101
Food restriction increases NMDA receptor-mediated calcium-calmodulin kinase II and NMDA receptor/extracellular signal-regulated kinase 1/2-mediated cyclic amp response element-binding protein phosphorylation in nucleus accumbens upon D-1 dopamine receptor stimulation in rats. Neuroscience 20050101
Bilateral control of brain activity by dopamine D1 receptors: evidence from induction patterns of regulator of G protein signaling 2 and c-fos mRNA in D1-challenged hemiparkinsonian rats. Neuroscience 20050101
Differential expression of striatal synaptotagmin mRNA isoforms in hemiparkinsonian rats. Neuroscience 20050101
Topographical effects of D1-like dopamine receptor agonists on orofacial movements in mice and their differential regulation via oppositional versus synergistic D1-like: D2-like interactions: cautionary observations on SK&F 82958 as an anomalous agent. Journal of psychopharmacology (Oxford, England) 20041201
Distinct patterns of Fos expression induced by systemic amphetamine in the striatal complex of C57BL/6JICo and DBA/2JICo inbred strains of mice. Brain research 20041029
Intranigral antagonism of neurokinin 1 and 3 receptors reduces intrastriatal dopamine D1 receptor-stimulated locomotion in the rat. Brain research 20041008
Differential effects of dopaminergic agents on locomotor sensitisation and on the reinstatement of cocaine-seeking and food-seeking behaviour. Psychopharmacology 20041001
The substantia nigra pars reticulata mediates the enhancement of startle by the dopamine D1 receptor agonist SKF 82958 in rats. Psychopharmacology 20040701
NMDA receptor blockade attenuates locomotion elicited by intrastriatal dopamine D1-receptor stimulation. Synapse (New York, N.Y.) 20040701
Induction of neurogenesis in the adult rat subventricular zone and neostriatum following dopamine D3 receptor stimulation. The European journal of neuroscience 20040501
Modification by dopaminergic drugs of choice behavior under concurrent schedules of intravenous saline and food delivery in monkeys. The Journal of pharmacology and experimental therapeutics 20040101
The effects of dopamine agonists and antagonists on the secretory responses in the salivary glands of the locust (Locusta migratoria). Journal of insect physiology 20040101
Effects of dopamine indirect agonists and selective D1-like and D2-like agonists and antagonists on cocaine self-administration and food maintained responding in rats. Neuropharmacology 20040101
Chromatin remodeling and neuronal response: multiple signaling pathways induce specific histone H3 modifications and early gene expression in hippocampal neurons. Journal of cell science 20031215
Opioid antagonists increase the dyskinetic response to dopaminergic agents in parkinsonian monkeys: interaction between dopamine and opioid systems. Neuropharmacology 20031201
Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats. Synapse (New York, N.Y.) 20031101
Effects of naloxone-precipitated morphine withdrawal on glutamate-mediated signaling in striatal neurons in vitro. Annals of the New York Academy of Sciences 20031101
Correlating brain metabolism with stereotypic and locomotor behavior. Behavior research methods, instruments, & computers : a journal of the Psychonomic Society, Inc 20030801
Blunted metabolic response to SKF 82958 in the mesolimbic system following preweaning cocaine treatment. Brain research. Developmental brain research 20030712
Comparison of the discriminative-stimulus effects of SKF 38393 with those of other dopamine receptor agonists. Behavioural pharmacology 20030501
The superior colliculus contains a discrete region involved in the control of jaw movements: role of GABAA receptors. European journal of pharmacology 20030319
Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats. Neuroscience 20030101
Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. The Journal of neuroscience : the official journal of the Society for Neuroscience 20021101
Cocaine and SKF-82958 potentiate brain stimulation reward in Swiss-Webster mice. Psychopharmacology 20020901
Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata. The Journal of pharmacology and experimental therapeutics 20020801
Dopaminergic and cholinergic stimulation of the ventrolateral striatum elicit rat jaw movements that are funnelled via distinct efferents. European journal of pharmacology 20020503
Impaired preprodynorphin, but not preproenkephalin, mRNA induction in the striatum of mGluR1 mutant mice in response to acute administration of the full dopamine D(1) agonist SKF-82958. Synapse (New York, N.Y.) 20020501
Effects of individual and concurrent stimulation of striatal D1 and D2 dopamine receptors on electrophysiological and behavioral output from rat basal ganglia. The Journal of pharmacology and experimental therapeutics 20020301
Tacrolimus, a specific inhibitor of calcineurin, modifies the locomotor activity of quinpirole, but not that of SKF82958, in male rats. European journal of pharmacology 20020301
Antagonistic effects of dopaminergic signaling and ethanol on protein kinase A-mediated phosphorylation of DARPP-32 and the NR1 subunit of the NMDA receptor. Alcoholism, clinical and experimental research 20020201
SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1. The Journal of biological chemistry 20020118
Alteration of glutamate receptors in the striatum of dyskinetic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated monkeys following dopamine agonist treatment. Progress in neuro-psychopharmacology & biological psychiatry 20020101
Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology 20020101
Dose-related alteration in nitric oxide synthase mRNA expression induced by amphetamine and the full D1 dopamine receptor agonist SKF-82958 in mouse striatum. Neuroscience letters 20010921
kappa-Opioid receptor agonist-induced prolactin release in primates is blocked by dopamine D(2)-like receptor agonists. European journal of pharmacology 20010706
N-tert-butyl-alpha-phenylnitrone, a free radical scavenger with anticholinesterase activity does not improve the cognitive performance of scopolamine-challenged rats. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20010601
Decreased striatal dopamine efflux after intrastriatal application of benzazepine-class D1 agonists is not mediated via dopamine receptors. Brain research bulletin 20010401
Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited. The Journal of neuroscience : the official journal of the Society for Neuroscience 20010301
Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum. The European journal of neuroscience 20010201
Intrastriatal GABA(A) receptor blockade does not alter dopamine D(1)/D(2) receptor interactions in the intact rat striatum. Neuroscience 20010101
Parafascicular thalamic nucleus deafferentation reduces c-fos expression induced by dopamine D-1 receptor stimulation in rat striatum. Neuroscience 20010101
Regulation of dopamine receptors and motor behavior following pulsatile and continuous dopaminergic replacement strategies in the MPTP primate model. Advances in neurology 20010101
Effects of dopamine D(1-like) and D(2-like) agonists on cocaine self-administration in rhesus monkeys: rapid assessment of cocaine dose-effect functions. Psychopharmacology 20000101
Comparison of dopamine receptor antagonists on hyperlocomotion induced by cocaine, amphetamine, MK-801 and the dopamine D1 agonist C-APB in mice. Psychopharmacology 19990801
5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB. Pharmacology, biochemistry, and behavior 19990601
Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. Journal of neurochemistry 19990201
The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease. Experimental neurology 19971101
Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience 19960601
Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. The European journal of neuroscience 19960201
(+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship. Journal of medicinal chemistry 19911201
Properties